Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

PharmaCyte Biotech Inc (PMCB) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.49

up-down-arrow $-0.01 (-1.04%)

As on 04-Sep-2026 12:13EDT

Market cap

info icon

$6 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- -- -19.39 4.62 -188.39
Net Profit -688.26 -137.39 -163.36 -235.73 -228.25
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsApr-26Apr-25Apr-24
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info 7.361.60-45.6167.080.59
Return on Capital info 7.361.60-45.6167.080.59
Return on Assets info 5.220.35-38.1253.280.50
Debt to Equity (x) info ----------

Profitability

View Detailed Peer Comparison

ROCE

-45.61

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
-45.61
67.08
0.59
-5.31
-8.77
Peer Median
--
--
--
--
--
ROE

-45.61

--

Profit after tax / Average Net worth * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
-45.61
67.08
0.59
-5.31
-8.78
Peer Median
--
--
--
--
--
ROA

-38.12

--

Profit after tax / Average Total assets * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
-38.12
53.28
0.50
-5.27
-8.65
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
--
7,773.36
103.10
-24.79
-20.36
Peer Median
--
--
--
--
--
Net Profit Growth

-163.36

--

Year on year growth in profit after tax

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
-163.36
9,084.98
107.73
-1.81
-19.37
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
--
--
--
--
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
--
--
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

45.28

--

Current Assets / Current Liabilities and Provisions

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
45.28
7.68
6.80
116.18
121.38
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
--
--
--
--
-16,956.81
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

EV/EBITDA

6.99

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
PharmaCyte Biotech Inc (PMCB)
6.99
3.55
7.70
10.54
20.15
Peer Median
--
--
--
--
--
loading...
loading...